NCT00354705 Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients Status UNKNOWN Phase N/A
NCT00351572 Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients Status COMPLETED Phase N/A
NCT00337389 Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. Status UNKNOWN Phase PHASE3
NCT00336856 Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy Status COMPLETED Phase PHASE2
NCT00335504 Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia Status COMPLETED Phase PHASE2
NCT00332163 Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy Status COMPLETED Phase PHASE2
NCT00250328 Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy Status UNKNOWN Phase PHASE1
NCT00245492 Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening. Status COMPLETED Phase NA
NCT00235898 Clinical Trial in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00200200 Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00197431 Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer Status UNKNOWN Phase PHASE2
NCT00193219 Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00193167 Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2